Dr. Kukar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-2391
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Surgery, 2007 - 2012
Kasturba Medical College ManipalClass of 2004
Certifications & Licensure
NY State Medical License 2012 - 2026
PA State Medical License 2012 - 2012
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer Start of enrollment: 2016 Dec 30
- Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism Start of enrollment: 2016 May 12
Publications & Presentations
PubMed
- Achieving textbook outcomes with robotic-assisted Ivor Lewis esophagectomy: a single-center experience with 150 consecutive patients.Faisal Jehan, Maureen Brady, Kristopher Attwood, Steven N Hochwald, Moshim Kukar
Journal of Gastrointestinal Surgery. 2025-04-01 - Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.Mark K Farrugia, Elizabeth A Repasky, Minhui Chen, Kristopher Attwood, Kayla Catalfamo
Cancer Immunology, Immunotherapy. 2025-01-03 - Chemotherapy switch for nonresponse or progression on neoadjuvant chemotherapy for pancreatic adenocarcinoma.Brendan L Hagerty, Fatemeh Fekrmandi, Tyce Schneider, Christos Fountzilas, Zachary Stiles
Journal of Surgical Oncology. 2024-10-01
Press Mentions
Novel Calculator Guides Treatment Choice in Esophageal CancerMarch 23rd, 2017
Novel Calculator More Easily Identifies Patients Who Will Benefit from Neoadjuvant ChemoradiationMarch 3rd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
